What is Melanotan I?
Melanotan I is afamelanotide/NDP-alpha-MSH, a melanocortin-1 receptor agonist with approved phototoxicity uses under Scenesse and research interest around pigmentation pathways.
Melanotan I dosage snapshot
- Route
- subQ
- Dose range
- 250-500 mcg reports
- Frequency
- protocol dependent
- Duration
- loading then maintenance
Based on reported research sources; not a dosing instruction.
Potential benefits
- Skin quality
- Hair support
- Collagen support
- Appearance
- Healthy aging
Safety profile
Unknown risk- Common: Route-specific irritation or tolerability issues may be reported depending on the compound.
- Less common: Headache, fatigue, appetite changes, or GI discomfort can appear in community or study contexts.
- Caution: Risk depends on dose, route, study model, duration, compound quality, and whether human data exists.
Storage and handling
Store according to product-label instructions and batch handling notes. Lyophilized research peptides are commonly kept dry, protected from light, and handled with clean laboratory technique.